382 related articles for article (PubMed ID: 18478749)
1. [Time for a European perspective on cardiovascular prevention].
Nilsson PM; Perk J; Rydén L
Lakartidningen; 2008 Apr 2-8; 105(14):1000-4. PubMed ID: 18478749
[No Abstract] [Full Text] [Related]
2. [Prevention of cardiovascular disease in type 2 diabetic patients].
Yokota C
Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078
[TBL] [Abstract][Full Text] [Related]
3. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U;
Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089
[TBL] [Abstract][Full Text] [Related]
4. [New European perspective concerning hypertension and cardiovascular risks].
Nilsson PM
Lakartidningen; 2003 Sep; 100(39):3036-40. PubMed ID: 14560668
[No Abstract] [Full Text] [Related]
5. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors.
Harris SB; Lank CN
Can Fam Physician; 2004 Mar; 50():425-33. PubMed ID: 15318682
[No Abstract] [Full Text] [Related]
6. Early screening for diabetes mellitus: has it been overstated?
Boucher FG
Can Fam Physician; 2004 Nov; 50():1503-4. PubMed ID: 15597968
[No Abstract] [Full Text] [Related]
7. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
Laakso M
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):682-3. PubMed ID: 18797431
[TBL] [Abstract][Full Text] [Related]
8. Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease.
Bethel MA; Califf RM
Am J Cardiol; 2007 Mar; 99(5):726-31. PubMed ID: 17317381
[TBL] [Abstract][Full Text] [Related]
9. [Treatment for patients with impaired glucose tolerance].
Tawaramoto K; Kaku K
Nihon Rinsho; 2005 Feb; 63 Suppl 2():423-7. PubMed ID: 15779416
[No Abstract] [Full Text] [Related]
10. [New guidelines put their faith in European standards. Not rigid instruction but guiding principle].
Aumiller J
MMW Fortschr Med; 2006 Feb; 148(7):41, 43-4. PubMed ID: 16529362
[No Abstract] [Full Text] [Related]
11. [Evidence-based reduction of complications of type 2 diabetes following intensive antihypertensive treatment].
Hansen KW; Poulsen PL; Mogensen CE
Ugeskr Laeger; 1999 Aug; 161(34):4764. PubMed ID: 10500468
[No Abstract] [Full Text] [Related]
12. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.
Sirois C; Moisan J; Poirier P; Grégoire JP
Diabetes Care; 2007 Jul; 30(7):1880-2. PubMed ID: 17384345
[No Abstract] [Full Text] [Related]
13. [ESH/ESC 2003].
Umemura S
Nihon Rinsho; 2006 Aug; 64 Suppl 6():562-8. PubMed ID: 16981591
[No Abstract] [Full Text] [Related]
14. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ;
Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406
[No Abstract] [Full Text] [Related]
15. [European Hypertension Congress initiative: implement modern risk management without further delay!].
Aumiller J
MMW Fortschr Med; 2005 Sep; 147(38):39, 41-2. PubMed ID: 16218227
[No Abstract] [Full Text] [Related]
16. [Diabetology 2007].
Scherbaum WA
Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1407-10. PubMed ID: 17570091
[No Abstract] [Full Text] [Related]
17. Multitherapy for diabetes.
Harris SB
CMAJ; 2006 Nov; 175(10):1247-8. PubMed ID: 17098959
[No Abstract] [Full Text] [Related]
18. Cardiovascular prevention in patients with diabetes and prediabetes.
Anselmino M; Gohlke H; Mellbin L; Rydén L
Herz; 2008 Apr; 33(3):170-7. PubMed ID: 18568310
[TBL] [Abstract][Full Text] [Related]
19. STOP-NIDDM: a new paradigm for diabetes prevention?
Hanefeld M
Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):253-8. PubMed ID: 12616804
[No Abstract] [Full Text] [Related]
20. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
; ; ; ; ;
Heart; 2005 Dec; 91 Suppl 5(Suppl 5):v1-52. PubMed ID: 16365341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
